Clinical Trials in Boston

Showing 6841-6860 of 17,836 trials

A Randomized Controlled Trial of an Advanced Care Planning Video Decision Support Tool for Patients With End-Stage Liver Disease

NCT03557086

The goal of this pilot randomized trial is to assess the feasibility and preliminary efficacy of an advanced care planning (ACP) video decision support tool for improving patients' knowledge regarding their goals of care options and end of life (EOL) decision-making in patients with end-stage liver disease (ESLD).

End Stage Liver Disease

Massachusetts General Hospital50 participantsStarted Sep 2018

Boston, Massachusetts, United States

COMPLETEDPhase 1/2< 1 mile

ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study

NCT04431258

A Phase I open label followed by a Phase II randomized, controlled study to assess the efficacy and safety of ABTL0812 in combination with FOLFIRINOX for first-line treatment of metastatic pancreatic. Funded by: FDA OOPD (Grant #FD-R-006817-01), H2020 EIC Accelerator (Grant #954825) and Ability Pharmaceuticals SL.

Pancreatic Cancer

Ability Pharmaceuticals SL150 participantsStarted May 2021

Los Angeles, California, United States • Westwood, Kansas, United States • Boston, Massachusetts, United States +21 more locations

A Randomized Controlled Trial of an Advanced Care Planning Video Decision Support Tool for Patients With End-Stage Liver Disease

ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study

Find Trials by Condition in Boston

Mindfulness Meditation for Insomnia

Chronic Plaque Psoriasis (Ps) Registry

Observational Study of Fostamatinib as Second Line Therapy in Adult Patients With Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior Therapy

Association of Platelet Parameters With Bleeding Severity in Children With ITP

Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes

DEFINing the PrEvalence and Characteristics of Coronary Artery Disease Among Patients With TYPE 2 Myocardial Infarction Using CT-FFR

Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200)

Losmapimod Safety and Efficacy in COVID-19

Feasibility Study of LUM Imaging System for Pancreatic Cancer

Development of a Resiliency Training Program for Parents of Children With Autism Spectrum Disorder

Study to Assess the Efficacy and Safety of Emapalumab in Primary Haemophagocytic Lymphohistiocytosis

Individually Targeted Neuromodulation for Contamination-based OCD

A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis

A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men

A System of Safety (SOS)

Investigating How the Brain Processes Different Experiences

Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations

Platform Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With aOX40 (GSK3174998) in Participants With RRMM